Thymosin Beta-4 Induces Adult Epicardial Progenitor Mobilization and Neovascularization
Smart N, Risebro CA, Melville AA, Moses K, Schwartz RJ, Bhatt DL, Riley PR
Nature · Vol. 445(7124) · pp. 177–182 · 2007
High-impact Nature study demonstrating that Thymosin Beta-4 (TB-500) reactivates dormant epicardial progenitor cells in the adult heart, promoting cardiac repair and neovascularization after myocardial infarction. This study elevated TB-500 from a wound healing peptide to a potential cardiac regeneration agent.
Key Findings
TB-500 reactivates dormant epicardial progenitor cells in the adult heart
Promotes neovascularization and cardiomyocyte survival after MI
Reduces infarct size and improves cardiac function in animal models
Mechanism involves Akt/PI3K signaling pathway activation
Basis for ongoing clinical trials in cardiac repair
Methodology
In vivo mouse model of myocardial infarction with TB-500 treatment. Includes lineage tracing, histological analysis, echocardiography, and mechanistic pathway studies.
Limitations
Animal model; human cardiac clinical trials ongoing but not yet completed. Cardiac doses may differ from musculoskeletal recovery doses.
Protocols Using This Research
Tags
Educational use only. Research summaries are provided for informational purposes. Always consult the original publication and a qualified healthcare provider before making clinical decisions.
Related Research
Build a protocol around this research
Our AI Advisor incorporates the latest research to build a personalized peptide protocol for your goals.
Start Assessment